Clinical trials
Phase 1 Lymphoma, T-Cell, Peripheral trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
96 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 8 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Terminated | 21 |
| Unknown status | 11 |
| Recruiting | 10 |
| Active, not recruiting | 4 |
| Not yet recruiting | 4 |
| Suspended | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 3 |
| Acrotech Biopharma Inc. | 2 |
| Barbara Ann Karmanos Cancer Institute | 2 |
| Case Comprehensive Cancer Center | 2 |
| City of Hope Medical Center | 2 |
| Henan Cancer Hospital | 2 |
| Pfizer | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 96 |
| Lymphoma, T-Cell, Cutaneous | 39 |
| Lymphoma, Large-Cell, Anaplastic | 36 |
| Lymphoma, Large B-Cell, Diffuse | 33 |
| Immunoblastic Lymphadenopathy | 31 |
| Lymphoma, Non-Hodgkin | 31 |
| Lymphoma, Extranodal NK-T-Cell | 29 |
| Hodgkin Disease | 28 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 27 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 26 |
Trials
Showing 26 to 50 of 96. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.